| Authors: |
Hamza A; Department of Genetics, Institut Curie, PSL Research University, Paris, France.; INSERM U1016, Paris Cité University, Faculty of Pharmaceutical and Biological Sciences, Paris, France., Gestraud P; Computational Oncology, PSL Research University, Mines Paris Tech, INSERM U91331, Paris, France., Karimi M; Service de Biostatistique et d'Épidémiologie, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Oncostat U1018, Inserm, Université Paris-Saclay, Équipe Labellisée Ligue Contre le Cancer, Villejuif, France., Tran-Dien A; Bioinformatics Platform, Gustave Roussy, Villejuif, France., Syx L; Computational Oncology, PSL Research University, Mines Paris Tech, INSERM U91331, Paris, France., Vacher S; Department of Genetics, Institut Curie, PSL Research University, Paris, France., Peretti Q; Department of Genetics, Institut Curie, PSL Research University, Paris, France., Lacroix L; Department of Medical Biology and Pathology, Gustave Roussy, Villejuif, France., Attignon V; Cancer Genomic Platform, Centre Léon Bérard, Lyon, France., Soubeyran I; Department of Biopathology, Institut Bergonié, Bordeaux, France., Jézéquel P; Omics and Data Science Unit, Institut de Cancérologie de l'Ouest (ICO), Angers-Nantes, France., Planchard D; Department of Medical Oncology, Gustave Roussy, Villejuif, France.; Paris Saclay University, Kremlin-Bicêtre, France., Melaabi S; Department of Genetics, Institut Curie, PSL Research University, Paris, France., Dailey-Chwalibóg T; Department of Food Technology, Safety and Health, Faculty of Bioscience Engineering, Ghent University, Ghent, Belgium.; Agence de Formation de Recherche et d'Expertise en Santé pour l'Afrique (AFRICSanté), Bobo-Dioulsso, Burkina Faso., Jimenez M; R&D Unicancer, Paris, France., Michiels S; Service de Biostatistique et d'Épidémiologie, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Oncostat U1018, Inserm, Université Paris-Saclay, Équipe Labellisée Ligue Contre le Cancer, Villejuif, France., Servant N; Computational Oncology, PSL Research University, Mines Paris Tech, INSERM U91331, Paris, France., Le Tourneau C; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France., Girard N; Thorax Institute Curie Montsouris, Department of Medical Oncology, Institut Curie, Paris, France., André F; Department of Medical Oncology, Gustave Roussy, Villejuif, France.; Gustave Roussy Cancer Campus, PRISM-PRecISion Medicine Center in Oncology, Villejuif, France.; Paris Saclay University, Kremlin-Bicêtre, France., Besse B; Department of Medical Oncology, Gustave Roussy, Villejuif, France., Kamal M; Department of Medical Oncology, Gustave Roussy, Villejuif, France.; Gustave Roussy Cancer Campus, PRISM-PRecISion Medicine Center in Oncology, Villejuif, France.; Paris Saclay University, Kremlin-Bicêtre, France., Barlesi F; Department of Medical Oncology, Gustave Roussy, Villejuif, France.; Paris Saclay University, Kremlin-Bicêtre, France., Bièche I; Department of Genetics, Institut Curie, PSL Research University, Paris, France. ivan.bieche@curie.fr.; INSERM U1016, Paris Cité University, Faculty of Pharmaceutical and Biological Sciences, Paris, France. ivan.bieche@curie.fr. |
